Temperament Dimensions and Awakening Cortisol Levels in Attention-Deficit/Hyperactivity Disorder.

ADHD arousal biomarkers cortisol temperament

Journal

Frontiers in psychiatry
ISSN: 1664-0640
Titre abrégé: Front Psychiatry
Pays: Switzerland
ID NLM: 101545006

Informations de publication

Date de publication:
2022
Historique:
received: 27 10 2021
accepted: 28 03 2022
entrez: 13 5 2022
pubmed: 14 5 2022
medline: 14 5 2022
Statut: epublish

Résumé

To investigate whether temperament dimensions, Effortful Control (EC), Surgency-Extraversion (SE), and Negative Affectivity (NA), are associated with attention-deficit/hyperactivity disorder (ADHD) and how they relate to awakening cortisol levels, as a proxy measure of peripheral arousal. Parent-rated temperament and saliva samples were collected from 55 children with ADHD and 65 age-matched controls. Compared to controls, youths with ADHD showed lower EC, higher NA, and lower awakening cortisol levels but did not differ in SE. Similar findings emerged in dimensional analyses linking temperament traits to inattention and hyperactivity-impulsivity symptoms. The results remained unchanged when controlling for the presence of co-occurring opposition-defiance and anxiety traits, as well as medication status. Temperament dimensions were not associated with cortisol levels. Poor temperamental emotional and cognitive self-regulation showed significant associations with ADHD but did not appear to be linked to the under-arousal typically seen in ADHD.

Identifiants

pubmed: 35546956
doi: 10.3389/fpsyt.2022.803001
pmc: PMC9081759
doi:

Types de publication

Journal Article

Langues

eng

Pagination

803001

Informations de copyright

Copyright © 2022 Carta, Vainieri, Rommel, Zuddas, Kuntsi, Sotgiu and Adamo.

Déclaration de conflit d'intérêts

JK has given talks at educational events sponsored by Medice; all funds are received by King's College London and used for studies of ADHD. AZ served in an advisory or consultancy role for Angelini, EduPharma, Servier. He received conference support or speaker's fee by Angelini and Janssen. He has been involved in clinical trials conducted by Angelini, Janssen, Lundbeck, Otsuka, Roche, Sevier, and Shire. He received royalties from Giunti OS, Oxford University Press. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The reviewer PK declared a shared affiliation with the A-SR at the time of review.

Références

J Psychiatr Res. 2012 Nov;46(11):1398-405
pubmed: 22974590
J Atten Disord. 2017 Feb;21(3):254-261
pubmed: 23223012
Dev Psychopathol. 2004 Spring;16(2):389-406
pubmed: 15487602
J Res Pers. 2008 Aug;42(4):895-913
pubmed: 19649133
J Psychiatr Res. 2012 Mar;46(3):415-6
pubmed: 22169529
Child Psychiatry Hum Dev. 2020 Apr;51(2):310-320
pubmed: 31624999
Child Dev. 2001 Sep-Oct;72(5):1394-408
pubmed: 11699677
Atten Defic Hyperact Disord. 2010 Dec;2(4):267-89
pubmed: 21432612
Pers Individ Dif. 2012 Nov 1;53(7):874-879
pubmed: 23139437
Psychiatry Res. 2011 May 15;187(1-2):204-9
pubmed: 20813414
Neuropsychobiology. 2020;79(4-5):255-269
pubmed: 32106115
Brain Behav Immun. 2020 Aug;88:105-113
pubmed: 32418647
J Clin Child Adolesc Psychol. 2004 Mar;33(1):54-68
pubmed: 15028541
Sci Rep. 2019 Apr 4;9(1):5639
pubmed: 30948735
Biol Psychiatry. 2005 Jun 1;57(11):1231-8
pubmed: 15949993
J Clin Child Adolesc Psychol. 2004 Mar;33(1):42-53
pubmed: 15028540
Psychoneuroendocrinology. 2018 Apr;90:174-181
pubmed: 29501948
J Child Psychol Psychiatry. 2006 Nov;47(11):1175-83
pubmed: 17076757
Psychoneuroendocrinology. 2009 Aug;34(7):1019-28
pubmed: 19278790
Atten Defic Hyperact Disord. 2012 Jun;4(2):63-75
pubmed: 22576746
Assessment. 2020 Sep;27(6):1258-1271
pubmed: 30991820
JAMA Psychiatry. 2018 Apr 1;75(4):408-409
pubmed: 29516086
J Abnorm Psychol. 2016 Feb;125(2):196-206
pubmed: 26854505
J Am Acad Child Adolesc Psychiatry. 2001 Feb;40(2):168-79
pubmed: 11211365
Child Psychiatry Hum Dev. 2008 Jun;39(2):201-9
pubmed: 17763937
J Abnorm Child Psychol. 2011 Feb;39(2):277-91
pubmed: 20862537
Dev Psychopathol. 2017 Feb;29(1):107-120
pubmed: 26751219
Biol Psychiatry Cogn Neurosci Neuroimaging. 2020 Aug;5(8):726-737
pubmed: 32305325
Behav Brain Funct. 2010 Jul 15;6:45
pubmed: 20633268
J Atten Disord. 2022 Apr;26(6):809-821
pubmed: 34378439
Neuropsychobiology. 2003;48(3):111-5
pubmed: 14586159
Life Sci. 1987 Jun 8;40(23):2247-52
pubmed: 3035307
JAMA Psychiatry. 2014 Sep;71(9):1015-24
pubmed: 25006969
Assessment. 2008 Sep;15(3):317-28
pubmed: 18310593
Ophthalmic Physiol Opt. 2014 Sep;34(5):502-8
pubmed: 24697967
J Clin Child Adolesc Psychol. 2004 Mar;33(1):82-7
pubmed: 15028543
Br J Psychol. 2018 May;109(2):277-298
pubmed: 28895129
J Educ Psychol. 2014;106(3):730-743
pubmed: 25308996
J Clin Child Adolesc Psychol. 2004 Mar;33(1):88-93
pubmed: 15028544
Dev Psychol. 2009 Jul;45(4):988-1008
pubmed: 19586175
J Abnorm Child Psychol. 1998 Aug;26(4):257-68
pubmed: 9700518
J Neural Transm (Vienna). 2016 Aug;123(8):991-1000
pubmed: 27106905
J Child Psychol Psychiatry. 2017 Apr;58(4):361-383
pubmed: 28035675
Dev Psychobiol. 1999 Nov;35(3):188-96
pubmed: 10531531
J Abnorm Child Psychol. 2009 Apr;37(3):337-48
pubmed: 18668361
J Res Pers. 2011 Oct;45(5):430-440
pubmed: 22581988
J Abnorm Child Psychol. 2018 Feb;46(2):265-276
pubmed: 28317068

Auteurs

Alessandra Carta (A)

Child Neuropsychiatry Unit, Department of Medical, Surgical and Experimental Sciences, University of Sassari, Sassari, Italy.
Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom.

Isabella Vainieri (I)

Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom.
South London and Maudsley National Health Service Foundation Trust, London, United Kingdom.

Anna-Sophie Rommel (AS)

Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom.
Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY, United States.

Alessandro Zuddas (A)

Department of Biomedical Sciences, Section of Neuroscience and Clinical Pharmacology, University of Cagliari, Cagliari, Italy.
Child and Adolescent Neuropsychiatry Unit, 'A.Cao', Paediatric Hospital, 'G. Brotzu' Hospital Trust, Cagliari, Italy.

Jonna Kuntsi (J)

Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom.

Stefano Sotgiu (S)

Child Neuropsychiatry Unit, Department of Medical, Surgical and Experimental Sciences, University of Sassari, Sassari, Italy.

Nicoletta Adamo (N)

Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom.
South London and Maudsley National Health Service Foundation Trust, London, United Kingdom.

Classifications MeSH